Members
| Location: | St.John's, Newfoundland |
|---|---|
| Industry Sector: | Public / Non-Profit Organizations |
| Website: | www.nati.net |
| Contact: |
Ron Taylor (ron@nati.net) 1 709 772 8324 |
| Description: | NATI represents the technology sector of the province of Newfoundland and Labrador, focusing on the information technology, geomatics, ocean technology, and biotechnology sectors. |
| Location: | Ottawa, Ontario |
|---|---|
| Industry Sector: | Public / Non-Profit Organizations |
| Website: | www.nrc-cnrc.gc.ca |
| Contact: |
John R. McDougall (info@nrc-cnrc.gc.ca) 1 613 9939101 |
| Description: | The National Research Council (NRC) is the Government of Canada's premier organization for research and development. |
| Location: | Saint-Laurent, Quebec |
|---|---|
| Industry Sector: | Public / Non-Profit Organizations |
| Website: | www.neomed.ca/ |
| Contact: |
(info@neomed.ca) 1 514 367-1212 |
| Description: | NEOMED is a not for profit organization intending to pioneer a new approach to drug development as a public-private partnership with government and biopharmaceutical companies. NEOMED has a full-time, dedicated, strong cross-functional team of experts with over 130 years of industry experience in R&D projects and alliances across Academia, Pharma and biotech. |
| Location: | London, Ontario |
|---|---|
| Industry Sector: | Biotechnology - other |
| Website: | www.neoventures.ca |
| Contact: |
Gregory Penner (gpenner@neoventures.ca) 1 519 858-5052 |
| Description: | NeoVentures Biotechnology Inc. is a leading independent Canadian company actively engaged in research, development and commercialization of agricultural biotechnology. The company has established global leadership in two areas; the development of aptamer diagnostic applications and the application of high throughput proteomics as a crop genetics discovery tool. NeoVentures was the first company globally to market an aptamer based diagnostic with their OTA-Sense technology for the detection of ochratoxin A in wine, beer and grain. They are following this success with ongoing product development for other commercially relevant targets including rapid varietal identification. NeoVentures has developed proprietary software and databases for the use of proteomics as a means of discovering novel protein sequences in wheat, and for the characterization of post-translational modifications of target proteins. The company’s business model is simple. We will be global leaders in regard to expertise and intellectual property over the next generation of tools for the analysis of grain and the improvement of crops. We will use this global leadership to create and sell products of commercial value. At NeoVentures we are committed to doing nothing less than creating the future of agriculture. |
| Location: | Mississauga, Ontario |
|---|---|
| Industry Sector: | Biotechnology - Therapeutics and Diagnostics |
| Website: | www.neuraxon.com |
| Contact: |
John S. Andrews (jsandrews@neuraxon.com) 1 416 6736697 |
| Description: | NeurAxon discovers and develops next generation pain therapeutics focused on the inhibition of neuronal nitric oxide synthase (nNOS), an enzyme involved in modulating pain and central nervous system neuronal sensitization. |
| Location: | Charlottetown, Prince Edward Island |
|---|---|
| Industry Sector: | Biotechnology - Therapeutics and Diagnostics |
| Website: | www.neurodyn.ca |
| Contact: |
Kenneth A. Cawkell 1 604 6190990 |
| Description: | Neurodyn Inc. (Neurodyn) is a Canadian biotechnology company focused on the discovery of products for early detection and treatment of neurological diseases. Company is developing novel therapeutic, ND-602, which has demonstrated in vivo pre-clinical efficacy in Amyotrophic Lateral Sclerosis (Lou Gehrig’s disease), Parkinson’s, Alzheimer’s and Spinal Muscular Atrophy (SMA). |
| Location: | Toronto, Ontario |
|---|---|
| Industry Sector: | Medical Technology |
| Website: | www.neuroimageinc.com/ |
| Contact: |
Adolfo Cotter (adolfo.cotter@neuroimageinc.com) 1 416 4575699 |
| Description: | NeuroImage Inc. has two components: 1) Brain imaging CRO. Full range of services. Including Clinical and Preclinical Imaging, Biomarkers, Molecular Imaging, etc 2) Actively engaged in new areas of Brain Fitness Software. |
| Location: | Toronto, Ontario |
|---|---|
| Industry Sector: | Biotechnology - Therapeutics and Diagnostics |
| Website: | www.nonoinc.ca |
| Contact: |
Michael Tymianski (info@nonoinc.ca) 1 416 6035481 |
| Description: | NoNO Inc. is a clinical-stage biotherapeutics company dedicated to the research, development and commercialization of pharmaceuticals for the treatment of common health disorders with unmet needs, including stroke, traumatic brain injury, and pain. |
| Location: | Toronto, Ontario |
|---|---|
| Industry Sector: | Professional Services and Consulting |
| Website: | www.nortonrose.com |
| Contact: |
Jeremy Gruschow (jeremy.grushcow@nortonrose.com) 1 416 2162301 |
| Description: | Norton Rose Group is a leading international legal practice. With more than 2900 lawyers, we offer a full business law service to corporations from offices in Canada, Europe, Asia, Africa, Australia, the Middle East, Central Asia and Latin America. We have a market leading pharmaceuticals and life sciences group helping clients achieve their objectives in this sector. |
| Location: | Dorval, Quebec |
|---|---|
| Industry Sector: | Pharma |
| Website: | www.novartis.ca |
| Contact: |
Julie Schneiderman (julie.schneiderman@novartis.com) 1 514 631 6775 |
| Ownership: | Subsidiary - New York Stock Exchange (NYSE): NVS |
| Description: | Novartis Pharmaceuticals Canada Inc. is a leading research-based company with a wide-ranging program for the development and marketing of innovative prescription medications in Canada. |
| Location: | Mississauga, Ontario |
|---|---|
| Industry Sector: | Pharma |
| Website: | www.novonordisk.ca |
| Contact: |
Lars Rebien Sørensen (nnci_customercare@novonordisk.com) 1 905 629 4222 |
| Ownership: | Subsidiary - OMX Copenhagen Stock Exchange (CSE): NVO |
| Description: | Novo Nordisk manufactures and markets pharmaceutical products and services, mainly focused on diabetes. Company has the broadest diabetes product portfolio in the industry, including advanced products within the area of insulin delivery systems. |
| Location: | Wellington, |
|---|---|
| Industry Sector: | Public / Non-Profit Organizations |
| Website: | www.nzbio.org.nz |
| Contact: |
Bronwyn Dilley (enquiries@nzbio.org.nz) 64 4 916 1243 |
| Description: | NZBIO is an incorporated society representing the New Zealand biotechnology sector. |
